BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31857685)

  • 1. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.
    Massé J; Truntzer C; Boidot R; Khalifa E; Pérot G; Velasco V; Mayeur L; Billerey-Larmonier C; Blanchard L; Charitansky H; Soubeyran I; Iggo R; Arnould L; MacGrogan G
    Mod Pathol; 2020 Jun; 33(6):1041-1055. PubMed ID: 31857685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: a comparison with adenoid cystic carcinoma.
    Baraban E; Zhang PJ; Jaffer S; Lubin D; Feldman M; Bleiweiss IJ; Nayak A
    Histopathology; 2018 Dec; 73(6):897-903. PubMed ID: 30003572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
    Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
    Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
    D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
    Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
    Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
    Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
    North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
    Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
    Bishop JA; Yonescu R; Epstein JI; Westra WH
    Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
    Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
    Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoid cystic and adenoid basal carcinoma of the uterine cervix: comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin.
    Grayson W; Taylor LF; Cooper K
    Am J Surg Pathol; 1999 Apr; 23(4):448-58. PubMed ID: 10199475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing.
    Fusco N; Colombo PE; Martelotto LG; De Filippo MR; Piscuoglio S; Ng CK; Lim RS; Jacot W; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    Histopathology; 2016 Jan; 68(2):262-71. PubMed ID: 25951887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
    Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
    Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.
    von Holstein SL; Fehr A; Persson M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
    Ophthalmology; 2013 Oct; 120(10):2130-8. PubMed ID: 23725736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.
    Stoeck A; Lejnine S; Truong A; Pan L; Wang H; Zang C; Yuan J; Ware C; MacLean J; Garrett-Engele PW; Kluk M; Laskey J; Haines BB; Moskaluk C; Zawel L; Fawell S; Gilliland G; Zhang T; Kremer BE; Knoechel B; Bernstein BE; Pear WS; Liu XS; Aster JC; Sathyanarayanan S
    Cancer Discov; 2014 Oct; 4(10):1154-67. PubMed ID: 25104330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscape of adenoid cystic carcinoma of the breast.
    Martelotto LG; De Filippo MR; Ng CK; Natrajan R; Fuhrmann L; Cyrta J; Piscuoglio S; Wen HC; Lim RS; Shen R; Schultheis AM; Wen YH; Edelweiss M; Mariani O; Stenman G; Chan TA; Colombo PE; Norton L; Vincent-Salomon A; Reis-Filho JS; Weigelt B
    J Pathol; 2015 Oct; 237(2):179-89. PubMed ID: 26095796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYB Translocations in Both Myoepithelial and Ductoglandular Epithelial Cells in Adenoid Cystic Carcinoma: A Histopathologic and Genetic Reappraisal in Six Primary Cutaneous Cases.
    Goto K; Kajimoto K; Sugino T; Nakatsuka SI; Yoshida M; Noto M; Kono M; Takai T
    Am J Dermatopathol; 2021 Apr; 43(4):278-283. PubMed ID: 32732690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma.
    Bell D; Roberts D; Karpowicz M; Hanna EY; Weber RS; El-Naggar AK
    Cancer Biol Ther; 2011 Oct; 12(7):569-73. PubMed ID: 21785271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYB expression: Potential role in separating adenoid cystic carcinoma (ACC) from pleomorphic adenoma (PA).
    Moon A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Oct; 44(10):799-804. PubMed ID: 27491495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
    Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
    Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterogeneity and therapeutic target detection through microdissection in solid-type adenoid cystic carcinoma.
    Wang Y; Sun B; Zhang C; Xia R; Sun J; Gu T; Tian Z; Li J
    Pathology; 2022 Aug; 54(5):580-590. PubMed ID: 35337667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
    Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.